{
  "trial_id": "NCT01632150",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, Eastern Cooperative Oncology Group (ECOG) performance status, number of prior lines of therapy, measurable disease status, serum immunoglobulin levels, urine M protein levels, serum free light chain levels, left ventricular ejection fraction, electrocardiogram QTc interval, presence of active plasma cell leukemia, hepatitis infection status, neuropathy grade.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "Eastern Cooperative Oncology Group (ECOG) performance status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Myeloma type"
      ],
      "remaining_candidate_features": [
        "number of prior lines of therapy",
        "measurable disease status",
        "serum immunoglobulin levels",
        "urine M protein levels",
        "serum free light chain levels",
        "left ventricular ejection fraction",
        "electrocardiogram QTc interval",
        "presence of active plasma cell leukemia",
        "hepatitis infection status",
        "neuropathy grade"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Eastern Cooperative Oncology Group (ECOG) performance status, Number of prior lines of therapy, Serum immunoglobulin levels, Urine M protein level, Serum free light chain level, Left ventricular ejection fraction, Electrocardiogram QTc interval,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "Eastern Cooperative Oncology Group (ECOG) performance status"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Myeloma type"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Number of prior lines of therapy",
        "Serum immunoglobulin levels",
        "Urine M protein level",
        "Serum free light chain level",
        "Left ventricular ejection fraction",
        "Electrocardiogram QTc interval"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Eastern Cooperative Oncology Group performance status, Number of prior lines of therapy, Measurable disease, Serum immunoglobulin level, Urine M protein level, Involved serum free light chain level, Left ventricular ejection fraction, Electrocardiogram finding of QTc,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "Eastern Cooperative Oncology Group performance status"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Myeloma type"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Number of prior lines of therapy",
        "Measurable disease",
        "Serum immunoglobulin level",
        "Urine M protein level",
        "Involved serum free light chain level",
        "Left ventricular ejection fraction",
        "Electrocardiogram finding of QTc"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, Eastern Cooperative Oncology Group performance status, number of prior lines of therapy, time since diagnosis, serum immunoglobulin levels, urine M protein levels, involved serum free light chain levels, free light chain ratio, left ventricular ejection fraction, electrocardiogram QTc interval, presence of plasma cell leukemia, presence of nonsecretory myeloma, presence of hepatitis A, B, or C virus infection, presence of neuropathy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) performance status",
          "Eastern Cooperative Oncology Group performance status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Myeloma type"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "number of prior lines of therapy",
        "time since diagnosis",
        "serum immunoglobulin levels",
        "urine M protein levels",
        "involved serum free light chain levels",
        "free light chain ratio",
        "left ventricular ejection fraction",
        "electrocardiogram QTc interval",
        "presence of plasma cell leukemia",
        "presence of nonsecretory myeloma",
        "presence of hepatitis A",
        "B",
        "or C virus infection",
        "presence of neuropathy."
      ]
    }
  }
}